Metabotropic or ''G-protein coupled'' glutamate receptors (mGluRs) wer
e discovered and established as a new type of excitatory amino acid re
ceptor by their unique coupling mechanism (phosphoinositide hydrolysis
) and pharmacological characteristics. Recently, the cloning of mGluRs
and the availability of selective pharmacological agents has greatly
increased knowledge of these receptors. It is now recognized that mGlu
Rs are a highly heterogenous family of glutamate receptors with novel
molecular structure that are linked to multiple second messenger pathw
ays. Members of this family have unique pharmacological properties and
function to modulate the presynaptic release of glutamate and the pos
tsynaptic sensitivity of the cell to glutamate excitation. New informa
tion on mGluRs is elucidating the functions of mGluR subtypes in norma
l and pathological aspects of neuronal transmission. Basic knowledge o
f the role of specific mGluRs in CNS function and pathologies will fur
ther expand in the near future. This knowledge is providing the framew
ork for the discovery of novel pharmacological approaches to modulate
excitatory amino acid neuronal transmission.